Prostate Cancer Risk Among Men with Diabetes Mellitus (Spain)
- A. González-PérezAffiliated withCentro Español de Investigación Farmacoepidemiológica (CEIFE) Email author
- , L.A. García RodríguezAffiliated withCentro Español de Investigación Farmacoepidemiológica (CEIFE)
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Objective: Observational studies have associated diabetes with a decreased risk of prostate cancer. We aimed to evaluate this association using the General Practitioner Research Database in the UK.
Methods: Population based case–control study nested in a cohort.
Results: We identified 2,183 incident cases of prostate cancer between January 1995 and December 2001. We found that diabetic patients had a decreased risk of prostate cancer (OR = 0.72; 95% CI: 0.59–0.87). This association was observed among treated diabetics (OR = 0.63; 95% CI: 0.50–0.80) but not among untreated diabetics (OR = 1.01; 95% CI: 0.73–1.40). Our results suggest that the observed reduced risk could be restricted to users of insulin or sulphonylureas.
Conclusion: Patients with diabetes have a decreased risk of prostate cancer. The role of antidiabetic treatment in this association warrants further research.
Keywordsdiabetes mellitus epidemiologic studies prostate cancer
- Prostate Cancer Risk Among Men with Diabetes Mellitus (Spain)
Cancer Causes & Control
Volume 16, Issue 9 , pp 1055-1058
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- diabetes mellitus
- epidemiologic studies
- prostate cancer
- Industry Sectors